Top in endocrinology: Bariatric surgery, hyperglycemia and COVID-19

A study showed that adults with obesity who were diagnosed with COVID-19 were less likely to suffer severe disease complications if they previously had bariatric surgery. It was one of the top stories in endocrinology last week.

Another top story was about data that indicated treating hyperglycemia lowered the odds of COVID-19 mortality in non-ICU patients.

Read these and more top stories in endocrinology below:

Prior bariatric surgery may reduce COVID-19 severity

Adults with obesity who tested positive for COVID-19 were significantly less likely to experience severe disease complications if they had previous bariatric surgery, according to findings from a matched-cohort analysis. Read more.

Treating hyperglycemia decreases COVID-19 mortality in non-ICU patients

Severe hyperglycemia after hospital admission for COVID-19 significantly increased mortality odds among individuals not in the ICU, according to a study published in Diabetes Care. Read more.

Similar increased risk for severe COVID-19 illness found in type 1, type 2 diabetes

Individuals with type 1 diabetes and those with type 2 diabetes have similar increased risks for COVID-19 hospitalization and severe illness compared with those without diabetes, according to a study published in Diabetes Care. Read more.

Hyperglycemia at admission predicts all-cause mortality after acute MI

Among adults without diabetes, hyperglycemia at hospital admission for acute myocardial infarction significantly increases the risk for all-cause mortality, and hyperglycemia is an independent predictor for morality, according to study data. Read more.

‘The vaccine is safe’: Endocrinologist E. Dale Abel shares his COVID-19 vaccine experience

Healio spoke with E. Dale Abel, MD, PhD, immediate past-president of the Endocrine Society, about his experiences as part of the first wave of clinicians to receive the COVID-19 vaccine. Read more.